EcoDrugPlus

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSECRG00000011129
Gene Symbol: KIT
3 Cross references
211 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSECRG00000005445
Gene Symbol: KRAS
3 Cross references
203 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSECRG00000003156
Gene Symbol: MALT1
3 Cross references
198 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSECRG00000004487
Gene Symbol: MAPKAPK2
3 Cross references
240 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSECRG00000011342
Gene Symbol: MKNK2
3 Cross references
226 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSECRG00000001608
Gene Symbol: MDM2
3 Cross references
285 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSECRG00000010782
Gene Symbol: MET
3 Cross references
207 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSECRG00000010292
Gene Symbol: MLST8
3 Cross references
203 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSECRG00000019284
Gene Symbol: NQO1
3 Cross references
195 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSECRG00000003650
Gene Symbol: NOX4
3 Cross references
150 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSECRG00000000331
Gene Symbol: NPC1L1
3 Cross references
190 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSECRG00000009883
Gene Symbol: LOC114658619
2 Cross references
271 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).